Exploratory Biomarkers
Serum and cerebrospinal fluid (CSF) were collected at baseline and end of study in order to assess liothyronine’s impact on neurotrophic/neuroprotective markers. SOMAscan platform (DNA aptamer based detection of proteins) was used to detect and quantify a panel of 1314 proteins in the CSF. 